With the success of immunotherapy in oncology for the past 5-10 years, there are also associated toxicities, including colitis. The current management strategy is mainly steroid, infliximab and/or vedolizumab based on small case reports and case series (1-6). These treatments are all associated with different toxicities. We are presenting alternative treatment of FMT for a very difficult case with ITIC.